How Tools And Technologies Bring Advanced Therapies To Market

Featuring James Taylor, co-founder and GM, Precision NanoSystems, and Clive Glover, General Manager, Gene Therapy, Pall

Companies like Pall, Cytiva, and Precision NanoSystems – one of the newest additions to the Danaher Life Sciences portfolio – can provide all of the technologies and expertise necessary to manufacture a drug. All scientists need to focus on is discovery.

Dr. James Taylor, Co-Founder and General Manager of Precision NanoSystems, and Dr. Clive Glover, General Manager, Gene Therapy, Pall answer questions about industry trends and the tools to support the development of RNA vaccines and therapeutics.